Ann Robbins, PhD

Ann Robbins is an experienced regulatory affairs consultant with 30 years of providing regulatory affairs expertise during preclinical and clinical development programs. She leads regulatory interactions from preparation of initial IND/CTA submissions to regulatory support of marketed products, with a focus on CNS and women’s health. Her industry experience includes Eli Lilly, Organon and Proctor & Gamble. She has a PhD in Neuroscience.